Faslodex (fulvestrant)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Faslodex (fulvestrant), covering 2018-03-13 to 2024-12-05. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer [Phase 2]